NGL Fine-Chem (BOM:524774) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is NGL Fine-Chem LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. NGL Fine-Chem's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

NGL Fine-Chem's long-term debt to total assets ratio declined from Mar. 2023 (0.01) to Mar. 2024 (0.00). It may suggest that NGL Fine-Chem is progressively becoming less dependent on debt to grow their business.

NGL Fine-Chem LT-Debt-to-Total-Asset Historical Data

The historical data trend for NGL Fine-Chem's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NGL Fine-Chem LT-Debt-to-Total-Asset Chart

NGL Fine-Chem Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.05

0.03

0.01

NGL Fine-Chem Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.01	-	-	-	-

NGL Fine-Chem LT-Debt-to-Total-Asset Calculation

NGL Fine-Chem's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	7.448	/	3555.358
	=	0.00

NGL Fine-Chem's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	7.448	/	3555.358
	=	0.00

NGL Fine-Chem (BOM:524774) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

NGL Fine-Chem LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of NGL Fine-Chem's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

NGL Fine-Chem (BOM:524774) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » NGL Fine-Chem Ltd (BOM:524774) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

NGLFINE:India

Address

301, E Square, Subhash Road, Vile Parle (East), Mumbai, MH, IND, 400057

Website

https://www.nglfinechem.com

NGL Fine-Chem Ltd is an Indian company engaged in the pharmaceutical business. The company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. Its product includes Active Pharmaceutical Ingredients (APIs) animal health, APIs human health, Intermediates and Finished dosage form, of which maximum revenue is generated from Veterinary APIs. Its geographical segments include India, Europe, Asia Pacific, United States, and Rest of the world. The Group's business activities fall within a single business segment of pharmaceuticals.

NGL Fine-Chem (BOM:524774) Headlines

No Headlines